Clover Health CEO Andrew Toy Testifies Before Congress on the Transformative Role of AI in Healthcare, Highlights how Clover is Leading the Way

(NASDAQ:CLOV) WASHINGTON, D.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) – Clover Health CEO Andrew Toy today had the honor to deliver testimony before the U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health, positioning Clover as a national leader in AI-enabled healthcare transformation. In his testimony, Andrew highlighted how Clover’s proprietary AI platform empowers physicians to deliver more personalized, timely care at the point of service, particularly to seniors in rural and other underserved communities. Motivated by a personal mission to improve care delivery following the loss of his father to complications from uncoordinated care, Andrew shared how Clover uses technology to simplify the healthcare experience and bring smarter, more proactive care to those who need it most.